Furthermore, comparison of the clinical and morphological results revealed a significant difference in H&E-based mitosis and Ki-67-based proliferation rates (ANOVA; P<0.05) between T1 and T3 stages, whereas no differences in mitosis and proliferation were observed with regard to primary tumor localizations. This evidence concerns the gene MKI67 and neoplasm.